1 National University of Singapore Yong Loo Lin School of Medicine, Singapore Background/aims To identify the risk factors for neuropathic corneal pain (NCP) following corneal refractive surgery and ...

Corneal disease is the primary cause of visual loss in allergic eye disease. It occurs almost exclusively in vernal keratoconjunctivitis and atopic keratoconjunctivitis. It is characterized by ...

一年一度的美国白内障与屈光手术学会年会（ASCRS）将于2025年4月25日至28日在美国洛杉矶盛大举行。本次会议亮点纷呈，通过座谈会、研讨会、课程、技能培训实验室、论文、海报和电影等多种形式，全方位展示白内障与屈光手术领域的最新前沿进展。万众瞩目的 ...

Last Tuesday and Wednesday, Angela Davis, political activist and professor emerita of history and feminist studies at the University of California, Santa Cruz, gave a series of lectures on abolition ...

These lecture notes on electromagnetism have evolved from graduate and undergraduate EM theory courses given by the author at the University of Rochester, with the basics presented with clarity and ...

The lecture hall of an "impressive high school" from an ancient Greek settlement was recently uncovered in Italy – with the discovery highlighting the similarities between ancient and modern ...

“FECD is a progressive corneal disease with no disease-modifying treatments currently available, ultimately leading to corneal transplant surgery for many patients. We believe DT-168, formulated ...

Muscat: The National Organ Transplant Programme seeks to localize corneal transplant services in the Sultanate of Oman by setting up an eye bank for collecting and preserving corneas from donors to ...

Saturday, April 26, 2025 | 7:30-9:30 p.m. The Smith College Department of Theatre presents Twelfth Night by William Shakespeare, directed by D ...

Holiday, who has hosted a series of lectures on the virtues of Stoicism to midshipmen for the past four years, was scheduled to speak to the sophomore class on the theme of wisdom on April 14.

Former US President Bill Clinton addressed an event to mark the 30th anniversary of the Oklahoma terror attack. Clinton said, "That bombing profoundly shook the ...

(Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that it will present an update on the progress of its DT-168 ...